Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis

被引:0
作者
Hakan Kisaoglu
Ozge Baba
Mukaddes Kalyoncu
机构
[1] Karadeniz Technical University Faculty of Medicine,Division of Pediatric Rheumatology
[2] Karadeniz Technical University Faculty of Medicine,Division of Pediatric Nephrology
来源
Pediatric Nephrology | 2023年 / 38卷
关键词
Autoimmune hemolytic anemia; Damage; Juvenile SLE; Lupus low disease activity state; Lupus nephritis; Kidney flare;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1167 / 1175
页数:8
相关论文
共 137 条
[1]  
Kamphuis S(2010)Prevalence and burden of pediatric-onset systemic lupus erythematosus Nat Rev Rheumatol 6 538-546
[2]  
Silverman ED(2021)Kidney outcomes for children with lupus nephritis Pediatr Nephrol 36 1377-1385
[3]  
Oni L(2020)2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis Ann Rheum Dis 79 713-723
[4]  
Wright RD(2017)European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative Ann Rheum Dis 76 1965-1973
[5]  
Marks S(2020)Treatment targets in SLE: remission and low disease activity state Rheumatology (Oxford) 59 v19-v28
[6]  
Beresford MW(2016)Definition and initial validation of a lupus low disease activity state (LLDAS) Ann Rheum Dis 75 1615-1621
[7]  
Tullus K(2019)How can we define low disease activity in systemic lupus erythematosus? Semin Arthritis Rheum 48 1035-1040
[8]  
Fanouriakis A(2021)LLDAS is an attainable treat-to-target goal in childhood-onset SLE Lupus Sci Med 8 3378-3389
[9]  
Kostopoulou M(2022)Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in Childhood Lupus Rheumatology (Oxford) 61 247-2686
[10]  
Cheema K(2017)Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus Arthritis Res Ther 19 2677-250